Your browser doesn't support javascript.
loading
[Techniques and complications of non-genetic risk reducing mastectomies: Guidelines of the National College of French Gynecologists and Obstetricians (CNGOF)]. / Modalités et morbidité des mastectomies de réduction de risque en dehors du risque avéré de prédisposition héréditaire : recommandations du Collège national des gynécologues et obstétriciens français (CNGOF).
Mathelin, C; Barranger, E; Boisserie-Lacroix, M; Boutet, G; Brousse, S; Chabbert-Buffet, N; Coutant, C; Daraï, E; Delpech, Y; Duraes, M; Espié, M; Golfier, F; Hamy, A S; Kermarrec, E; Lavoué, V; Lodi, M; Luporsi, É; Maugard, C; Molière, S; Seror, J-Y; Taris, N; Uzan, C; Vaysse, C; Fritel, X.
Afiliação
  • Mathelin C; CHRU, avenue Molière, 67200 Strasbourg, France; ICANS, 17, rue Albert-Calmette, 67033 Strasbourg cedex, France. Electronic address: c.mathelin@icans.eu.
  • Barranger E; Centre Antoine-Lacassagne, 36, avenue de Valombrose, 06189 Nice, France.
  • Boisserie-Lacroix M; Institut Bergonié, 229, cours de l'Argonne, 33000 Bordeaux, France.
  • Boutet G; AGREGA, service de chirurgie gynécologique et médecine de la reproduction, centre Aliénor d'Aquitaine, centre hospitalier universitaire de Bordeaux, groupe hospitalier Pellegrin, place Amélie-Raba-Léon, 33 000 Bordeaux, France.
  • Brousse S; CHU de Rennes, 2, rue Henri-le-Guilloux, 35033 Rennes cedex 9, France.
  • Chabbert-Buffet N; Hôpital Tenon, 4, rue de la Chine, 75020 Paris, France.
  • Coutant C; Département d'oncologie chirurgicale, centre Georges-François-Leclerc, 1, rue du Pr Marion, 21079 Dijon cedex, France.
  • Daraï E; Hôpital Tenon, 4, rue de la Chine, 75020 Paris, France.
  • Delpech Y; Centre Antoine Lacassagne, 33, avenue de Valombrose, 06189 Nice, France.
  • Duraes M; CHU de Montpellier, 191, avenue du Doyen-Giraud, 34295 Montpellier cedex, France.
  • Espié M; Hôpital St Louis, 1, avenue Claude-Vellefaux, 75010 Paris, France.
  • Golfier F; Centre hospitalier Lyon Sud, bâtiment 3B, 165, chemin du Grand-Revoyet, 69495 Pierre Benite, France.
  • Hamy AS; Institut Curie, 26, rue d'Ulm, 75248 Paris, France.
  • Kermarrec E; Service de radiologie, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France.
  • Lavoué V; Service de gynécologie, CHU, 16, boulevard de Bulgarie, 35200 Rennes, France.
  • Lodi M; CHU, avenue Molière, 67200 Strasbourg, France.
  • Luporsi É; Oncologie médicale et oncogénétique, hôpital de Mercy, CHR Metz-Thionville, 1, allée du Château, 57085 Metz, France.
  • Maugard C; Service de génétique oncologique clinique et unité de génétique oncologique moléculaire, hôpitaux universitaires de Strasbourg, 1, avenue Molière, 67200 Strasbourg.
  • Molière S; Imagerie du sein, CHRU, avenue Molière 67200 Strasbourg, France.
  • Seror JY; Cabinet privé, 9 ter boulevard Montparnasse, 75006 Paris, France.
  • Taris N; Oncogénétique, ICANS, 17, rue Albert Calmette, 67033 Strasbourg, France.
  • Uzan C; Hôpital Pitié-Salpetrière, 47, boulevard de l'Hôpital, 75013 Paris, France.
  • Vaysse C; Service de chirurgie oncologique, CHU de Toulouse, institut universitaire du cancer de Toulouse-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse, France.
  • Fritel X; Centre hospitalo-universitaire de Poitiers, 2, rue de la Milétrie, 86021 Poitiers, France.
Gynecol Obstet Fertil Senol ; 50(2): 121-129, 2022 Feb.
Article em Fr | MEDLINE | ID: mdl-34922037
ABSTRACT

OBJECTIVE:

Based on an updated review of the international literature covering the different surgical techniques and complications of risk reducing mastectomies (RRM) in non-genetic context, the Commission of Senology (CS) of the College National des Gynécologues Obstétriciens Français (CNGOF) aimed to establish recommendations on the techniques to be chosen and their implementation.

DESIGN:

The CNGOF CS, composed of 24 experts, developed these recommendations. A policy of declaration and monitoring of links of interest was applied throughout the process of making the recommendations. Similarly, the development of these recommendations did not benefit from any funding from a company marketing a health product. The CS adhered to and followed the AGREE II (Advancing guideline development, reporting and evaluation in healthcare) criteria and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) method to assess the quality of the evidence on which the recommendations were based. The potential drawbacks of making recommendations in the presence of poor quality or insufficient evidence were highlighted.

METHODS:

The CS considered 6 questions in 4 thematic areas, focusing on oncologic safety, risk of complications, aesthetic satisfaction and psychological impact, and preoperative modalities.

RESULTS:

The application of the GRADE method resulted in 7 recommendations, 6 with a high level of evidence (GRADE 1±) and 1 with a low level of evidence (GRADE 2±).

CONCLUSION:

There was significant agreement among the CS members on recommendations for preferred surgical techniques and practical implementation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mastectomia Tipo de estudo: Etiology_studies / Guideline / Risk_factors_studies Limite: Humans Idioma: Fr Revista: Gynecol Obstet Fertil Senol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mastectomia Tipo de estudo: Etiology_studies / Guideline / Risk_factors_studies Limite: Humans Idioma: Fr Revista: Gynecol Obstet Fertil Senol Ano de publicação: 2022 Tipo de documento: Article